Home
Statistics
Acknowledgment
Enquire
Keyword Search
Complex Search
Segment Search
Peptide Mapping
Browse On
Mode of delivery
Animal model
Origin/Source
Peptide Length
Similarity
BLAST Search
Smith-Waterman
General
Help or Guide
Data Submission
Curators
Developers
Contact Us
Browse result page of B3Pdb
The total number entries retrieved from this search are
137
, scroll left/right for detailed information.
B3pdbID
PEPTIDE NAME
PEPTIDE SEQUENCE (1-letter)
PEPTIDE SEQUENCE (3-letter)
N-TERMINAL MODIFICATION
C-TERMINAL MODIFICATION
CHEMICAL MODIFICATION
PEPTIDE LENGTH
PEPTIDE CONFORMATION
PEPTIDE NATURE
SOURCE/ORIGIN OF PEPTIDE
SMILES
CELL LINE
In vitro
CONCENTRATION
In vitro
METHOD
In vitro
RESULT
ANIMAL MODEL
In vivo
CONCENTRATION
In vivo
MODE OF DELIVERY
In vivo
METHOD
In vivo
RESULT
ACTION
TRANSPORT TYPE
SUBCELLULAR LOCALISATION
COMBINATION
PHYSICAL CONDITION
RESPONSE
RESULT
LABEL
PMID
b3pdb_0926
Oncocin
VDKPPYLPRPRPPRRIYNR-NH2
Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.02584 ml/g
Direct iodination
24164260
b3pdb_0927
Drosocin (unglycosyl
GKPRPYSPRPTSHPRPIRV
Gly-Lys-Pro-Arg-Pro-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-Val
NA
NA
NA
19
Linear
NA
Gila monster
NA
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain elemination rate constant
0.217 min-1
Direct iodination
24164260
b3pdb_0928
Drosocin (unglycosyl
GKPRPYSPRPTSHPRPIRV
Gly-Lys-Pro-Arg-Pro-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-Val
NA
NA
NA
19
Linear
NA
Gila monster
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
33%
Direct iodination
24164260
b3pdb_0929
Drosocin (unglycosyl
GKPRPYSPRPTSHPRPIRV
Gly-Lys-Pro-Arg-Pro-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-Val
NA
NA
NA
19
Linear
NA
Gila monster
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
67%
Direct iodination
24164260
b3pdb_0930
Drosocin (unglycosyl
GKPRPYSPRPTSHPRPIRV
Gly-Lys-Pro-Arg-Pro-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-Val
NA
NA
NA
19
Linear
NA
Gila monster
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00086 mL/(g x min)
Direct iodination
24164260
b3pdb_0931
Drosocin (unglycosyl
GKPRPYSPRPTSHPRPIRV
Gly-Lys-Pro-Arg-Pro-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-Val
NA
NA
NA
19
Linear
NA
Gila monster
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.01962 ml/g
Direct iodination
24164260
b3pdb_0932
Drosocin Pro5Hyp (un
GKPR-Hyp-YSPRPTSHPRPIR
Gly-Lys-Pro-Arg-4t-Hyp-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-Val
NA
NA
NA
19
Linear
NA
synthetic,milkweed bug
NA
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain elemination rate constant
-0.079 min-1
Direct iodination
24164260
b3pdb_0933
Drosocin Pro5Hyp (un
GKPR-Hyp-YSPRPTSHPRPIR
Gly-Lys-Pro-Arg-4t-Hyp-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-Val
NA
NA
NA
19
Linear
NA
synthetic,milkweed bug
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
33%
Direct iodination
24164260
b3pdb_0934
Drosocin Pro5Hyp (un
GKPR-Hyp-YSPRPTSHPRPIR
Gly-Lys-Pro-Arg-4t-Hyp-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-Val
NA
NA
NA
19
Linear
NA
synthetic,milkweed bug
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
67%
Direct iodination
24164260
b3pdb_0935
Drosocin Pro5Hyp (un
GKPR-Hyp-YSPRPTSHPRPIR
Gly-Lys-Pro-Arg-4t-Hyp-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-Val
NA
NA
NA
19
Linear
NA
synthetic,milkweed bug
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00037 mL/(g x min)
Direct iodination
24164260
b3pdb_0936
Drosocin Pro5Hyp (un
GKPR-Hyp-YSPRPTSHPRPIR
Gly-Lys-Pro-Arg-4t-Hyp-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-Val
NA
NA
NA
19
Linear
NA
synthetic,milkweed bug
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.01957 ml/g
Direct iodination
24164260
b3pdb_0964
ANG1005
(2'-N-succinimide-paclitaxel)TFFYGGSRG-(2'-N-succinimide-paclitaxel)KRNNF(2'-N-succinimide-paclitaxel)KTEEY
(2'-N-succinimide-paclitaxel)Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-(2'-N-succinimide-paclitaxel)Lys-Arg-Asn-Asn-Phe-(2'-N-succinimide-paclitaxel)Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(brain/perfusate)
0.9333 ml/g
H3/C14
18574456
b3pdb_0965
ANG1005
(2'-N-succinimide-paclitaxel)TFFYGGSRG-(2'-N-succinimide-paclitaxel)KRNNF(2'-N-succinimide-paclitaxel)KTEEY
(2'-N-succinimide-paclitaxel)Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-(2'-N-succinimide-paclitaxel)Lys-Arg-Asn-Asn-Phe-(2'-N-succinimide-paclitaxel)Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(capillary/perfusate)
0.3111 ml/g
H3/C14
18574456
b3pdb_0966
ANG1005
(2'-N-succinimide-paclitaxel)TFFYGGSRG-(2'-N-succinimide-paclitaxel)KRNNF(2'-N-succinimide-paclitaxel)KTEEY
(2'-N-succinimide-paclitaxel)Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-(2'-N-succinimide-paclitaxel)Lys-Arg-Asn-Asn-Phe-(2'-N-succinimide-paclitaxel)Lys-Thr-Glu-Glu-Tyr
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(parenchyma/perfusate)
0.5037 ml/g
H3/C14
18574456
b3pdb_0967
Benzylpenicillin-Syn
Benzylpenicillin-RGGRLSYSRRRFSTSTGR
Benzylpenicillin-Arg-Gly-Gly-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-Ser-Thr-Ser-Thr-Gly-Arg
NA
NA
NA
18
Linear
NA
mouse
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
20%
H3/C14
12164379
b3pdb_0968
Benzylpenicillin-Syn
Benzylpenicillin-RGGRLSYSRRRFSTSTGR
Benzylpenicillin-Arg-Gly-Gly-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-Ser-Thr-Ser-Thr-Gly-Arg
NA
NA
NA
18
Linear
NA
mouse
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
80%
Direct iodination
12164379
b3pdb_0969
Doxorubicin-SynB1
Doxorubicin-linker-RGGRLSYSRRRFSTSTGR
Doxorubicin-linker-Arg-Gly-Gly-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-Ser-Thr-Ser-Thr-Gly-Arg
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
In situ perfusion (single time)
NA
NA
NA
Permeability
NA
NA
NA
Unidirectonal influx rate constant
0.0684 mL/(g x min)
H3/C14
12164379
b3pdb_0970
Doxorubicin-(D)-Pene
Doxorubicin-linker-rqikiwfqnrrmkwkk
Doxorubicin-linker-(D)Arg-(D)Gln-(D)Ile-(D)Lys-(D)Ile-(D)Trp-(D)Phe-(D)Gln-(D)Asn-(D)Arg-(D)Arg-(D)Met-(D)Lys-(D)Trp-(D)Lys-(D)Lys
NA
16
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Volume of donor compartment
0.77764 ml/g
H3/C14
11123372
b3pdb_0971
Doxorubicin-(D)-Pene
Doxorubicin-linker-rqikiwfqnrrmkwkk
Doxorubicin-linker-(D)Arg-(D)Gln-(D)Ile-(D)Lys-(D)Ile-(D)Trp-(D)Phe-(D)Gln-(D)Asn-(D)Arg-(D)Arg-(D)Met-(D)Lys-(D)Trp-(D)Lys-(D)Lys
NA
NA
NA
16
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
In situ perfusion (single time)
NA
NA
NA
Permeability
NA
NA
NA
Unidirectonal influx rate constant
0.072 mL/(g x min)
H3/C14
10727512
b3pdb_0980
pVEC
LLIILRRRIRKQAHAHSK-NH2
Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain elemination rate constant
0.1019 min-1
Direct iodination
26465925
b3pdb_0981
pVEC
LLIILRRRIRKQAHAHSK-NH2
Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
19.53%
Direct iodination
26465925
b3pdb_0982
pVEC
LLIILRRRIRKQAHAHSK-NH2
Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
80.47%
Direct iodination
26465925
b3pdb_0983
pVEC
LLIILRRRIRKQAHAHSK-NH2
Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00602 mL/(g x min)
Direct iodination
26465925
b3pdb_0984
pVEC
LLIILRRRIRKQAHAHSK-NH2
Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.02313 ml/g
Direct iodination
26465925
b3pdb_1111
BIP-2
GLWEDLLYNINRYAHYIT
Gly-Leu-Trp-Glu-Asp-Leu-Leu-Tyr-Asn-Ile-Asn-Arg-Tyr-Ala-His-Tyr-Ile-Thr
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain elemination rate constant
0.06 min-1
Direct iodination
26536593
b3pdb_1112
BIP-2
GLWEDLLYNINRYAHYIT
Gly-Leu-Trp-Glu-Asp-Leu-Leu-Tyr-Asn-Ile-Asn-Arg-Tyr-Ala-His-Tyr-Ile-Thr
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
76.90%
Direct iodination
26536593
b3pdb_1113
BIP-2
GLWEDLLYNINRYAHYIT
Gly-Leu-Trp-Glu-Asp-Leu-Leu-Tyr-Asn-Ile-Asn-Arg-Tyr-Ala-His-Tyr-Ile-Thr
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
23.10%
Direct iodination
26536593
b3pdb_1114
BIP-2
GLWEDLLYNINRYAHYIT
Gly-Leu-Trp-Glu-Asp-Leu-Leu-Tyr-Asn-Ile-Asn-Arg-Tyr-Ala-His-Tyr-Ile-Thr
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00035 mL/(g x min)
Direct iodination
26536593
b3pdb_1115
BIP-2
GLWEDLLYNINRYAHYIT
Gly-Leu-Trp-Glu-Asp-Leu-Leu-Tyr-Asn-Ile-Asn-Arg-Tyr-Ala-His-Tyr-Ile-Thr
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.01267 ml/g
Direct iodination
26536593
b3pdb_1145
gH625
HGLASTLTRWAHYNALIRA
His-Gly-Leu-Ala-Ser-Thr-Leu-Thr-Arg-Trp-Ala-His-Tyr-Asn-Ala-Leu-Ile-Arg-Ala
NA
NA
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
Imaging techniques
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain to plasma ratio
0.09
Fluorescent label
25792823
b3pdb_1176
L57
TWPKHFDKHTFYSILKLGKH
Thr-Trp-Pro-Lys-His-Phe-Asp-Lys-His-Thr-Phe-Tyr-Ser-Ile-Leu-Lys-Leu-Gly-Lys-His
NA
NA
NA
20
Linear
NA
Hemoglobin
NA
NA
NA
NA
NA
NA
NA
In situ perfusion (single time)
NA
NA
NA
Permeability
NA
NA
NA
% injected dose
0.22 %/g
Direct iodination
29090274
b3pdb_1177
L57
TWPKHFDKHTFYSILKLGKH
Thr-Trp-Pro-Lys-His-Phe-Asp-Lys-His-Thr-Phe-Tyr-Ser-Ile-Leu-Lys-Leu-Gly-Lys-His
NA
NA
NA
20
Linear
NA
Hemoglobin
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
% injected dose
0.042 %/g
Direct iodination
29090274
b3pdb_1190
Macrocyclic inhibito
cGflGGrrrGfGGIGGc
Cys-Gly-Phe-Leu-Gly-Gly-Arg-Arg-Arg-Gly-Phe-Gly-Gly-Ile-Gly-Gly-Cys
NA
NA
NA
17
Linear
NA
Chemically synthesized
NA
NA
NA
Initial concentration in donor chamber-Culture
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Parallel artificial membrane permeation assay apparent permiability cofficient
14.6 cm/s
Fluorescent label
29908130
b3pdb_1208
Adiponetic peptide
LQVYGDGDHNGLYADNVN
NA
NA
NA
NA
18
Linear
NA
NA
NA
NA
NA
NA
NA
C57BL/6J mice
15 mg/kg of APNp
Intraperitoneal
Fourier Transform Infrared Spectroscopy
APNp suppressed mitochondrial and ATF4-CHOP apoptosis pathways in a Smad3 dependent manner.
NA
Permeability
NA
Alone
ICH injury in diabetic mice
NA
APNp promoted neural sur- vival following ICH injury in the diabetic setting, by suppressing mitocho
NA
31922310
b3pdb_1209
Penetratin
RQIKIWFQNRRMKWKK
NA
NA
NA
NA
16
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
Male Sprague-Dawley rats
2.0 mM
Intranasal
ELISA
L-penetratin increased the systemic absorption of leptin after intranasal administration.
The intranasal coadministration with L-penetratin could deliver leptin to the brain and in particula
Permeability
Hypothalamus
Combined with leptin
Obesity
NA
The intranasal coadministration with L-penetratin has a potential to deliver leptin into the therape
NA
31926192
b3pdb_1223
D-penetratin
RQIKIWFQNRRMKWKK
NA
NA
NA
NA
16
NA
NA
Chemically synthesized
NA
In situ brain perfusion technique
NA
Capillary depletion method
Vectorization of dox led to a 20-fold increase in the amount of dox transportation.
Male Sprague-Dawley rats
2.5 mg/kg
Intravenous
Capillary depletion method
It led to a significant increase in brain dox concentrations during the first 30 min of postadminist
The use of these peptide vectors for brain delivery of dox.
Transcytosis
Brain parenchyma
Combined with Doxorubicin
NA
NA
NA
NA
10727512
b3pdb_1224
SynB1
RGGRLSYSRRRFSTSTGR
NA
NA
NA
NA
18
NA
NA
Chemically synthesized
NA
In situ brain perfusion technique
NA
Capillary depletion method
Vectorization of dox led to a 20-fold increase in the amount of dox transportation.
Male Sprague-Dawley rats
2.5 mg/kg
Intravenous
Capillary depletion method
It led to a significant increase in brain dox concentrations during the first 30 min of postadminist
The use of these peptide vectors for brain delivery of dox.
Transcytosis
Brain parenchyma
Combined with Doxorubicin
NA
NA
NA
NA
10727512
previous
1
2
3
next
IIITD/CB
Raghava's Group
IMTECH
CellPPDMOD